Announce Date | 05/01/2025 |
EPS Normalized Actual | $2.67 (Beat by $0.0099999999999998) |
EPS GAAP Actual | $2.67 (Beat by $0.0099999999999998) |
Revenue Actual | $5.956B |
Revenue Surprise | Beat by $5956M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $3.47451 |
EPS GAAP Estimate | $3.47451 |
Revenue Estimate | $7.170700947B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 16.08 | 19.51 | 15.59965 | 16.86741 | 2 |
Dec 2028 | 18.44 | 17.01 | 17.78135 | 18.95861 | 4 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 2.6 | 2.6 | 5.956B | -3.58% | 5956M |
FQ4 2024 (Dec 2024) | 2.81 | 2.81 | 6.388B | -0.28% | 6388M |
FQ3 2024 (Sep 2024) | 0 | 0 | 6.873B | 2.63% | 6873M |
FQ2 2024 (Jun 2024) | 0 | 0 | 6.49B | -0.12% | 6490M |
FQ1 2024 (Mar 2024) | 2.66 | 2.66 | 6.169B | 4.4% | 6169M |
FQ4 2023 (Dec 2023) | 2.82 | 2.82 | 6.4062B | 7.49% | 6406.2M |
FQ3 2023 (Sep 2023) | 3.18 | 3.18 | 6.6922B | 12.25% | 6692.2M |
FQ2 2023 (Jun 2023) | 3.16 | 3.16 | 6.4975B | 11.99% | 6497.5M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
3.47451
Consensus Revenue Estimates
7.170700947B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 3.94169 | -- | 3.82161 | 4.12207 | 13 |
FQ2 2027 (Jun 2027) | 3.57528 | -- | 3.46636 | 3.73889 | 8 |
FQ1 2027 (Mar 2027) | 3.18401 | -- | 3.08631 | 3.32897 | 8 |
FQ4 2026 (Oct 2026) | 3.9174 | -- | 3.72467 | 4.00825 | 8 |
FQ3 2026 (Jul 2026) | 3.65903 | -- | 3.47901 | 3.74389 | 9 |
FQ2 2026 (Jun 2026) | 3.79157 | -- | 3.54603 | 3.89468 | 17 |
FQ1 2026 (Mar 2026) | 3.22532 | 19.39 | 3.01645 | 3.31303 | 8 |
FQ4 2025 (Oct 2025) | 3.60479 | 22.05 | 3.42744 | 3.68839 | 12 |
FQ3 2025 (Jul 2025) | 3.37043 | -- | 3.20461 | 3.4486 | 9 |
FQ2 2025 (Jun 2025) | 3.47451 | -- | 3.2495 | 3.569 | 12 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 7.72B | -- | 7.54B | 7.99B | 8 |
FQ2 2027 (Jun 2027) | 7.37B | -- | 7.2B | 7.63B | 8 |
FQ1 2027 (Mar 2027) | 6.86B | -- | 6.7B | 7.1B | 8 |
FQ4 2026 (Oct 2026) | 7.92B | -- | 7.62B | 8.06B | 8 |
FQ3 2026 (Jul 2026) | 7.55B | -- | 7.26B | 7.69B | 13 |
FQ2 2026 (Jun 2026) | 7.71B | -- | 7.32B | 7.87B | 13 |
FQ1 2026 (Mar 2026) | 6.91B | 13.78 | 6.56B | 7.05B | 8 |
FQ4 2025 (Oct 2025) | 7.41B | 13.81 | 7.13B | 7.54B | 7 |
FQ3 2025 (Jul 2025) | 7.05B | 2.49 | 6.78B | 7.17B | 8 |
FQ2 2025 (Jun 2025) | 7.17B | 9.49 | 6.81B | 7.32B | 8 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
0
EPS # of in-lines
2
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 2.6 | 2.6 | 100% | |
FQ4 2024 (Dec 2024) | 2.81 | 2.81 | 100% | |
FQ3 2024 (Sep 2024) | 0 | 0 | NAN% | |
FQ2 2024 (Jun 2024) | 0 | 0 | NAN% | |
FQ1 2024 (Mar 2024) | 2.66 | 2.66 | 100% | |
FQ4 2023 (Dec 2023) | 2.82 | 2.82 | 100% | |
FQ3 2023 (Sep 2023) | 3.18 | 3.18 | 100% | |
FQ2 2023 (Jun 2023) | 3.16 | 3.16 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $5.96B | $5956M | 100% |
FQ4 2024 (Dec 2024) | $0B | $6.39B | $6388M | 100% |
FQ3 2024 (Sep 2024) | $0B | $6.87B | $6873M | 100% |
FQ2 2024 (Jun 2024) | $0B | $6.49B | $6490M | 100% |
FQ1 2024 (Mar 2024) | $0B | $6.17B | $6169M | 100% |
FQ4 2023 (Dec 2023) | $0B | $6.41B | $6406.2M | 100% |
FQ3 2023 (Sep 2023) | $0B | $6.69B | $6692.2M | 100% |
FQ2 2023 (Jun 2023) | $0B | $6.5B | $6497.5M | 100% |